Testing for the essential biologic markers of antiretroviral treatment revealed that 54.5% of the patients had a robust CD4 cell count ≥ 500 cells/mm3 (HIV infection, stage 1) and 68.9% of them achieved plasma viral load suppression below the detection limit of 20 copies/mL. This evidence concerns the gene CD4 and HIV infectious disease.